Non-Hodgkin's Lymphoma

Paper Summary:

This paper discusses the use of radio immunotherapy for the treatment of Non-Hodgkin's Lymphomas. The paper presents a definition and explanation of cancer in general and how it affects the human body. The paper examines Non-Hodgkin's Lymphoma, exploring how it manifests in the patient, the various symptoms involved, and the many different types of this cancer. Different methods of treatment are outlined, with a focus on radio immunotherapy.

From the Paper:

"Non-Hodgkin's lymphoma is the type of cancer that affects the lymphatic system that comprises the immune system of the human body. When this type of cancer is to be treated with any results, a combination therapy is what works best. The traditional CHOPS, that is, a treatment that is a chemotherapy combination comprising of cyclophosphamide, doxorubicin, Oncovin, and prednisone, was the method of treatment that had been used until recently. It was after intensive research began to be conducted into more effective and better treatment methods that the treatment regimens of Zevalin and Bexxar were evolved. Zevalin combines cell targeting and cell killing in one package, and this is achieved through a combination of a monoclonal antibody that targets a cell, and a radioactive particle or in other words, a 'radioisotope', called 'yttrium-90' that kills a cell. This mode of treatment is a part of the radioimmunotherapy methods that are being researched today, when the practitioners of Nuclear Medicine use radioisotopes as part of the treatment regimens followed for non-Hodgkin's lymphoma treatment."

More papers on Non-Hodgkin's Lymphoma:

• Essay # 86458 : "Pathophysiology of Non-Hodgkin's Lymphoma"
• Research Paper # 120343 : "Treatment for Non-Hodgkin's Lymphoma"
• Term Paper # 104727 : "Non-Hodgkin's Lymphoma"

APA Citation:

MLA Citation: